MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-25-0003484
Avik Pharmaceutical Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹103.38 Cr
▲ 29% YoY
Net profit · FY 2025
₹15.58 Cr
Net margin 15.1%
EBITDA · FY 2025
₹24.95 Cr
EBITDA margin 24.1%
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹10.88 Cr
Issued & subscribed
Open charges
₹25.43 Cr
Satisfied ₹19.02 Cr
Company age
47 yrs
Est. 1979
Employees · EPFO
174
Provident fund records
About Avik Pharmaceutical Limited
Data last updated:
Avik Pharmaceutical Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 25 September 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1979PLC021711. Its GSTIN is 27AAACA5490R1Z3 (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹10.88 Cr. It was formerly known as Avik Pharmaceuticals Limited and Avik Pharmaceuticals Private Limited. It is led by directors including Anant Rajendralal Thakore (Managing Director) and Neha Anant Thakore (Whole-Time Director).
Its last annual general meeting (AGM) was held on 11 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹103.38 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹15.58 Cr (net margin 15.1%) and EBITDA of ₹24.95 Cr (EBITDA margin 24.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.
The company has about 174 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Avik Pharmaceuticals. As per MCA filings, the company has open charges of ₹25.43 Cr and satisfied charges of ₹19.02 Cr on record. Court records list 56 cases involving the company, including 18 filed by the company and 38 filed against it; 3 cases are pending. The company has 11 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹10.46 Cr; the latest was in January 2022. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Panchsheel Organics Limited with revenue of ₹107.68 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2024, listing 91 overdue payments to 31 micro and small suppliers.
Avik Pharmaceutical Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-25-0003484). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avikpharma.com.
Company details
CIN U99999MH1979PLC021711
Registration Number 021711
Incorporation Date 25 September 1979
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-25-0003484
Name history
Avik Pharmaceutical has undergone 2 name changes throughout its history. The company was previously known as Avik Pharmaceuticals Limited, and Avik Pharmaceuticals Private Limited. The current legal name is Avik Pharmaceutical Limited.
| Company Name | Status |
|---|---|
| Avik Pharmaceutical Limited | Current |
| Avik Pharmaceuticals Limited | Previous |
| Avik Pharmaceuticals Private Limited | Previous |
CIN history
Avik Pharmaceutical has one previous CIN (Corporate Identification Number): U99999MH1979PTC021711. The current CIN is U99999MH1979PLC021711, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999MH1979PLC021711 | Current |
| U99999MH1979PTC021711 | Previous |
Key People
Anant Rajendralal Thakore Managing Director Neha Anant Thakore Whole-Time Director Jeevan Lal Nagori Director Recognitions & Rankings of Avik Pharmaceutical
Contact details
Avik Pharmaceutical Limited's registered office is in Mumbai, Maharashtra. Its website is avikpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressArvind Chambers Gauri Compound 188 Kurla Road Ground Floor Western Express Highway An, Dheri (E), Mumbai, Maharashtra, India – 400069
- IndustryPharma, API Manufacturers
To see the full contact details of Avik Pharmaceutical Limited, buy the company report.
Comprehensive company report
Avik Pharmaceutical Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Avik Pharmaceutical operates one associated brand: Avik Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures corticosteroids and steroid APIs for pharmaceutical industry. | avikpharma.com |
Business activity
The main business activity of Avik Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Avik Pharmaceutical Limited, buy the company report.
Financials of Avik Pharmaceutical Limited
FY 2025 filings availableAvik Pharmaceutical Limited reported revenue of ₹103.38 Cr (up 29% YoY) for FY 2025.
Revenue · FY 2025
₹103.38 Cr ▲ 29%
Net profit · FY 2025
₹15.58 Cr margin 15.1%
EBITDA · FY 2025
₹24.95 Cr margin 24.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 82%
3 years · compounded
▲ 49%
Revenue has grown at a compounded annual rate (CAGR) of 17% over three years, including 29% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.58 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.1% | ||||
| Net Profit Margin | 15.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avik Pharmaceutical Limited, buy the company report.
Board of directors and KMP of Avik Pharmaceutical Limited
Avik Pharmaceutical Limited currently reports 5 directors and 1 key managerial person. 9 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jeevan Lal Nagori | Director | 18 Nov 2013 | 12 Years 11 Months | Current |
| Anant Rajendralal Thakore Also directs: Anantco Pharmachem Private Limited | Managing Director | 25 Sep 1979 | 47 Years 1 Months | Current |
| Neha Anant Thakore Also directs: Anantco Pharmachem Private Limited, Themis Medicare Limited, Relic Technologies Limited and 1 more | Whole-Time Director | 04 Jan 2022 | 4 Years 9 Months | Current |
| Rajeshree Maruti Chougule Also directs: Priya International Limited, Priya Limited | Company Secretary | 19 Dec 2024 | 1 Years 10 Months | Current |
| Raj Kamal Prasad Verma Also directs: Makers Laboratories Ltd, Resonance Specialties Limited, Evse Ready India Private Limited and 2 more | Director | 16 Sep 2024 | 2 Years 1 Months | Current |
| Sushil Kumar Kumra | Director | 16 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Avik Pharmaceutical Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Panchsheel Organics Limited | ₹107.68 Cr (FY 2024) | 3.0% | Indore, Madhya Pradesh, India | |||
| Patel Chem Specialities Limited | ₹105.55 Cr (FY 2025) | 28.0% | Ahmedabad, Gujarat, India | |||
| Lucent Drugs Private Limited | ₹104.13 Cr (FY 2025) | 101.0% | Sanathnagar, Telangana, India | |||
| Novo Excipients Private Limited | ₹103.54 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Par Active Technologies Private Limited | ₹103.46 Cr (FY 2025) | 2.0% | Chennai, Tamil Nadu, India | |||
| Avik Pharmaceutical Limitedthis company | ₹103.38 Cr (FY 2025) | ₹15.58 Cr | 15.1% | 29.0% | 174 | Mumbai, Maharashtra, India |
| Sriven Pharmachem India Private Limited | ₹102.76 Cr (FY 2025) | 2.0% | Hyderabad, Telangana, India | |||
| Vineet Life Sciences Limited | ₹101.85 Cr (FY 2024) | 48.0% | Hyderabad, Telangana, India | |||
| Sna Healthcare Private Limited | ₹101.57 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Sarv Bio Labs Private Limited | ₹101.4 Cr (FY 2024) | -10.0% | Himachal Pradesh, India | |||
| Valens Molecules Private Limited | ₹100.32 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Avik Pharmaceutical Limited, buy the company report.
Auditor
Avik Pharmaceutical Limited is audited by AGRAWAL & MANGAL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWAL & MANGAL | FY 2023 | 100061W |
Shareholding
The shareholding of Avik Pharmaceutical Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avik Pharmaceutical Limited, buy the company report.
Charges & borrowings
Open charges
₹25.43 Cr
Satisfied charges
₹19.02 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jun 2025 | 101111400 | Yes Bank Limited | ₹5 Cr | Open | |
| 20 May 2015 | 10574529 | Yes Bank Limited | ₹20.43 Cr | Open | |
| 21 Apr 1999 | 90346899 | Indian Bank | ₹12.39 Cr | Satisfied | |
| 04 Mar 1998 | 90346846 | Central Bank of India | ₹1.3 Cr | Satisfied | |
| 28 Apr 1994 | 90347533 | Indian Bank | ₹25 Lakh | Satisfied |
To see the full charge records of Avik Pharmaceutical Limited, buy the company report.
Total charge records: 23 View all charges
Deals & funding
Avik Pharmaceutical Limited has 11 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹10.46 Cr; the latest was in January 2022.
Total deals
11
Secondary share transfers
7
Funding rounds
3
Rights issue
1
Disclosed funding
₹10.46 Cr
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2022 | Secondary share transfer | Undisclosed | Buyer: Ipca Laboratories Limited Seller: 2 individuals |
| Oct 2018 | Rights issue | ₹68 Lakh | Investors: Ipca Laboratories Limited , 3 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Anantco Enterprises Private Limited , 3 individuals |
| Nov 2013 | Funding round | ₹5.81 Cr | Investors: Ipca Laboratories Limited |
| Nov 2013 | Secondary share transfer | Undisclosed | Buyer: Ipca Laboratories Limited Seller: Bloom Packaging Private Limited, Shatatarka Holdings P. Ltd, Dramuk Holdings P. Ltd, an individual |
To see the full deal history of Avik Pharmaceutical Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Avik Pharmaceutical Limited has 56 court cases on record: 18 filed by Avik Pharmaceutical, 38 filed against it. 3 cases are pending and 53 are disposed.
Total cases
56
Filed by the company
18
Filed against the company
38
Pending
3
Disposed
53
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 35 | 30 | 2 |
| High courts | 20 | 8 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 56)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Valsad, Gujarat | Court case (SPCS) | Filed by the company against M/S.Bennett Coleman and Co.Ltd and 4 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed by the company against Somil Enterprises Pvt Ltd and 3 others | Disposed |
| District court, Valsad, Gujarat | Court case (SPCS) | Filed by the company against M/S.Bennett Coleman and Co.Ltd and 4 others | Disposed |
| High Court, TELANGANA | Revision petition | Filed by the company against M/S.Vasudha Pharma Chem Ltd | Disposed |
| Bombay High Court | Court case (CNPCP) | Filed against the company by G.E.Capital Transportation Financial Services Ltd. | Disposed |
To see the full case history of Avik Pharmaceutical Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Avik Pharmaceutical Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 91 overdue payments to 31 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 31)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| S Kant Chemicals Private Limited |
To see the full MSME payment records of Avik Pharmaceutical Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Avik Pharmaceutical has 1 joint venture. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Joint ventures
Employees & EPFO
Avik Pharmaceutical Limited has a workforce of 174 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
174
Active EPFO establishments
1
Employee growth
-4.4%
GST
Avik Pharmaceutical has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA5490R1Z3 | Maharashtra | Active | 01 Jul 2017 |
| 27AAACA5490R2Z2 | Maharashtra | Active | 07 Sep 2017 |
| 24AAACA5490R1Z9 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avik Pharmaceutical Limited, buy the company report.
Recent activity
Avik Pharmaceutical Limited has 18 board changes on record since 1979: 12 appointments and 6 cessations. The latest: Chandrashekar Koraga Shetty ceased to be CFO on 09 Jun 2025.
AGM
Avik Pharmaceutical Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records.
Ceased
Chandrashekar Koraga Shetty ceased to be CFO.
Charges
A charge with Yes Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101111400 was registered on 04 Jun 2025.
Filing
Avik Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Rajeshree Maruti Chougule was appointed as Company Secretary.
Ceased
Madhu Thakorlal Ankleshwaria ceased to be Director.
Ceased
Popatlal Mukanchand Kathariya ceased to be Director.
Appointed
Raj Kamal Prasad Verma was appointed as Director.
Appointed
Sushil Kumar Kumra was appointed as Director.
Charges
A charge with Yes Bank Limited of Rs. 20.43 Cr registered on 20 May 2015 with Charge ID 10574529 was modified on 20 Feb 2023.
Ceased
Babu Jaicob Edakklathur ceased to be Director.
Appointed
Neha Anant Thakore was appointed as Whole-Time Director.
65 earlier events are in the company report.
Frequently asked questions
Avik Pharmaceutical is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 25 September 1979 (47+ years old) and is registered under CIN U99999MH1979PLC021711.
Avik Pharmaceutical has 6 current directors and KMP:
- Anant Rajendralal Thakore - Managing Director
- Neha Anant Thakore - Whole-Time Director
- Jeevan Lal Nagori - Director
- Raj Kamal Prasad Verma - Director
- Sushil Kumar Kumra - Director
- Rajeshree Maruti Chougule - Company Secretary
The latest financial statements of Avik Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Avik Pharmaceutical is 27AAACA5490R1Z3, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 27AAACA5490R2Z2 (Maharashtra), 24AAACA5490R1Z9 (Gujarat).
The CIN (Corporate Identification Number) of Avik Pharmaceutical is U99999MH1979PLC021711. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avik Pharmaceutical has 56 court cases on record: 18 filed by the company and 38 filed against it. 3 are pending. Most are in the district courts.
Avik Pharmaceutical was incorporated on 25 September 1979, making it 47+ years old. It is registered with the Registrar of Companies, Mumbai.
Avik Pharmaceutical has 11 deals on record (7 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹10.46 Cr; the latest was in January 2022.
The peers of Avik Pharmaceutical by revenue are Panchsheel Organics Limited, Patel Chem Specialities Limited, Lucent Drugs Private Limited, Novo Excipients Private Limited, Par Active Technologies Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandrashekar Koraga Shetty ceased to be CFO on 09 Jun 2025. Rajeshree Maruti Chougule was appointed as Company Secretary on 19 Dec 2024. Madhu Thakorlal Ankleshwaria ceased to be Director on 17 Sep 2024. Avik Pharmaceutical has 18 board changes on record in total.
Yes, Avik Pharmaceutical is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-25-0003484).
Avik Pharmaceutical has 13 MSME Form 1 returns on record between 2019 and 2024, listing 91 overdue payments to 31 micro and small suppliers. The latest return was filed on 04 Jul 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages